Teleflex Receives FDA 510(k) Clearance for Antithrombogenic Claims on its ARROW® Peripherally Inserted Central Catheter (PICC) with Chlorag+ard® Technology

Monday May 21st 2012 05:00:00 PM

World's First Chlorhexidine Protected Antimicrobial PICC now proven to reduce thrombus accumulation on catheter surfaces for at least 30 days LIMERICK, Pa.--(BUSINESS WIRE)--May. 21, 2012-- Teleflex Incorporated (NYSE:TFX) announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW® PICC with Chlorag+ard® Technology provides antithrombogenic protection for at least 30 days. It's the world's first central venous catheter to significantly reduce the risk of two common complications associated with peripherally inserted central catheters, compared to traditional uncoated PICCs. Chlorag+ard technology uses a proprietary formulation and process p...

Teleflex to Focus on Innovative Critical Care Products at the Nurses’ National Teaching Institute & Critical Care Exposition

Friday May 18th 2012 07:00:00 AM

Products and education designed to help providers improve outcomes LIMERICK, Pa.--(BUSINESS WIRE)--May. 18, 2012-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will showcase a number of anesthesia, respiratory therapy and vascular access products at the American Association of Critical-Care Nurses' National Teaching Institute & Critical Care Exposition (AACN-NTI) on May 19-24, 2012 in Orlando, Florida. Teleflex will highlight: The Teleflex ISIS® HVT™, the first convertible endotracheal tube, features an integrated suction port and separate suction line allowing for subglottic secretion suctioning on demand. Now cli...

Teleflex Announces Quarterly Dividend

Friday May 4th 2012 05:02:11 PM

LIMERICK, Pa., May 04, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2012 to shareholders of record at the close of business on May 15, 2012. Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11...

Teleflex to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

Wednesday May 2nd 2012 07:02:00 AM

LIMERICK, Pa., May 02, 2012 (BUSINESS WIRE) --Benson F. Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV at Encore at the Wynn on Wednesday, May 16, 2012 at 1:40 p.m. (PT). An audio webcast and an accompanying slide presentation will be available on the investor portion of the Teleflex website at http://www.teleflex.com. About Teleflex Incorporated Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and en...

Teleflex Reports First Quarter 2012 Results

Tuesday May 1st 2012 07:02:00 AM

Revenues Rise 9.5% to $387.8 million; up 10.9% Constant Currency GAAP EPS of ($6.97); $1.01 on Adjusted EPS basis Records Non Cash Impairment Charge Due to Reallocation of Goodwill Balances Reaffirms 2012 Guidance for Constant Currency Revenue Growth and Adjusted EPS Ranges LIMERICK, Pa., May 01, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE: TFX) today announced financial results for the first quarter ended April 1, 2012. First quarter 2012 net revenues were $387.8 million, an increase of 9.5% over the prior year period. Excluding the impact of foreign exchange, first quarter 2012 net revenues increased 10.9% over the prior year period. First quarter 2012 GAAP loss per share ...

Teleflex Acquires Innovative Technology for Lung Isolation Procedures

Tuesday May 1st 2012 06:46:00 AM

LIMERICK, Pa., May 01, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, announced it has acquired the EZ-BlockerTM disposable catheter product line with a unique bifurcated distal end, a novel and patented bronchial blocker for lung isolation and one-lung ventilation. The acquisition is consistent with the company's strategy to invest in late-stage, innovative technology to support its future growth. The EZ-Blocker, a 7 Fr., 4 lumen, 75 cm, disposable catheter, is designed to enable easy, quick placement with minimal risk of dislocation during surgery, which supports patient safety and allows for simplified...

Teleflex Enters into Definitive Agreement to Acquire Laparoscopic Fascial Closure System

Tuesday May 1st 2012 06:31:00 AM

LIMERICK, Pa., May 01, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced it has entered into a definitive agreement to acquire substantially all of the assets of Axiom Technology Partners, LLC, which makes the EFx family of laparoscopic fascial closure system products. This acquisition is expected to broaden our general surgery product line and provide access to new sales channels. The EFx product portfolio includes both FDA-cleared and pipeline products designed for the safe and simple closure of abdominal trocar defects through which access ports and instruments were used during laparoscopic...

Teleflex Introduces Softech(R) Plus for Oxygen Therapy Proprietary Non-DEHP Material Compound

Monday April 30th 2012 05:01:00 PM

LIMERICK, Pa., Apr 30, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE: TFX) has announced the introduction of Hudson RCI® Softech Plus, a line of oxygen cannulas designed to help clinicians improve patient comfort and reduce DEHP exposure. When it comes to respiratory care, patients and caregivers around the world look to Hudson RCI for innovative products that provide added safety and comfort. Softech Plus is the ideal choice for comfortable, safe oxygen delivery using an advanced combination of soft, non-DEHP material and improved product design. The Softech Plus line of adult, pediatric, infant and neonatal oxygen cannulas feature a soft material in both the cannula and the lariat...

Teleflex to Present at the Deutsche Bank 37th Annual Health Care Conference

Tuesday April 24th 2012 07:01:00 AM

LIMERICK, Pa., Apr 24, 2012 (BUSINESS WIRE) --Benson F. Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the Deutsche Bank 37th Annual Health Care Conference at the InterContinental Hotel in Boston, Massachusetts, on Tuesday, May 8, 2012 at 2:50 p.m. (ET). An audio webcast and an accompanying slide presentation will be available on the investor portion of the Teleflex website at http://www.teleflex.com. About Teleflex Incorporated Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes a...

Teleflex Announces First Quarter 2012 Conference Call Information

Tuesday April 17th 2012 07:02:30 AM

Live Webcast is scheduled at 8:00 a.m. (ET) on Tuesday, May 1, 2012 LIMERICK, Pa., Apr 17, 2012 (BUSINESS WIRE) --Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2012, will be released before market open on Tuesday, May 1, 2012. An investor conference call will be held at 8:00 a.m. (ET) on Tuesday, May 1, 2012. The call can be accessed through a live audio webcast on the company's website, www.teleflex.com. A replay of the call will also be available on the website. In addition, an audio replay will be available from May 1 to May 8, 2012 by calling 888-286-8010 (U.S./Canada) or 61...